NIH names Jeanne Marrazzo to lead top US infectious diseases agency

2023-08-02

高管变更疫苗

The US National Institutes of Health (NIH) on Wednesday announced that Jeanne Marrazzo has been selected to run the National Institute of Allergy and Infectious Diseases (NIAID)Infectious Diseases (NIAID). The incoming director, currently head of the infectious diseases division at the University of Alabama, takes up her new role in the fall and succeeds Anthony Fauci, who led the NIH unit for 38 years before stepping down last December.

With an annual budget of $6.3 billion, NIAID is the second largest of the NIH's 27 institutes and centres, after the National Cancer Institute Cancer Institute. Acting NIH director Lawrence Tabak stated that Marrazzo "brings a wealth of leadership experience from leading international clinical trials and translational research, managing a complex organisational budget that includes research funding and mentoring trainees in all stages of professional development."

Her scientific work has focused on the human microbiome, specifically as it relates to female reproductive tract infections and hormonal contraception, as well as the prevention of HIV infection using biomedical interventions, including PrEP and microbicides, and the pathogenesis and management of bacterial vaginosis, sexually transmitted diseases in HIV-infected patients and management of antibiotic resistance in gonorrhoea.

NIAID supports research at universities and research organisations around the US and across the unit's 21 laboratories, including the Vaccine Research Center where Ted Pierson was recently appointed director. It is also mandated to respond to emerging and re-emerging public health threats in the US and abroad. Hugh Auchincloss has been acting director of NIAID since Fauci's departure at the end of last year. The NIH can install Marrazzo in the post without a presidential appointment or confirmation by the US Senate.

Meanwhile, the Biden administration has not been able to secure a permanent appointment to run the broader NIH agency after long-time director Francis Collins stepped down at the end of 2021. Monica Bertagnolli was nominated in May, but Senator Bernie Sanders has said he will not hold a hearing on any health nominee until he sees a "robust" plan from the White House about lowering drug prices.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构

National Institute of Allergy & Infectious Diseases